✦ LIBER ✦

A randomized, double-blind, sponsor-unblinded, placebo- and positive-controlled study to evaluate the effects of single oral administrations of PF-04995274 on scopolamine-induced deficits in cognitive function in healthy adults

✍ Scribed by Leurent, Claire; Duvvuri, Sridhar; Raunig, David; Antinew, Jeremias; Rowinski, Carolyn; Zumpano, Laura; Bergeron, Michelle; Kocinsky, Hetal; Sieklucki, Joy; Nicolas, Timothy; Rapp, Tracey L.

Book ID: 122919766
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 64 KB
Volume: 8
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2012.05.1586

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind, placebo-controlled study

A double-blind, placebo-controlled study of the effects of eptastigmine on scopolamine-induced cognitive deficits in healthy male subjects

✍ C. R. Lines; J. H. Ambrose; A. Heald; M. Traub 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 612 KB

This double-blind, placebo-controlled, crossover study examined the effects of two single doses of eptastigmine, a novel cholinesterase inhibitor, on scopolamine-induced cognitive deficits in 24 healthy male volunteers. Each subject received the following treatment sequences, separated by at least 1

Double-blind, randomized, placebo-contro

Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers

✍ N. J. TALLEY; M. CAMILLERI; D. BURTON; G. THOMFORDE; K. KOCH; M. J. RUCKER; J. P 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

P2-377: A phase 2, double-blind, placebo

P2-377: A phase 2, double-blind, placebo-controlled study to evaluate the safety, tolerability, and effect on cognitive function of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment

✍ Schmechel, Donald E.; Gerard, Gary; Vatakis, Nick G.; Harper, Linda; Ross, Joel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB